Aiforia Technologies Oyj Valuation

Q: What is the Fair Price of L6J when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

L6J (€4.03) is trading below our estimate of [[fair value]] (€4.63)

Is L6J undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of L6J when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: L6J (€4.03) is trading below our estimate of fair value (€4.63)

Significantly Below Fair Value: L6J is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for L6J?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for L6J. This is calculated by dividing L6J's market cap by their current preferred multiple.
What is L6J's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	€116.53m

L6J key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	37.5x
Enterprise Value/EBITDA	-8.5x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does L6J's PS Ratio compare to its peers?

The above table shows the PS ratio for L6J vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.8x
M3V MeVis Medical Solutions	2.4x	n/a	€41.9m
AJ91 DocCheck	0.7x	n/a	€38.3m
NXU Nexus	3.5x	9.5%	€918.5m
COP CompuGroup Medical SE KGaA	0.6x	1.7%	€728.9m
L6J Aiforia Technologies Oyj	41.5x	50.9%	€116.5m

Price-To-Sales vs Peers: L6J is expensive based on its Price-To-Sales Ratio (41.5x) compared to the peer average (1.8x).

Price to Earnings Ratio vs Industry

How does L6J's PE Ratio compare vs other companies in the European Healthcare Services Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	26.1%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	26.1%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: L6J is expensive based on its Price-To-Sales Ratio (41.5x) compared to the European Healthcare Services industry average (2.3x).

Price to Sales Ratio vs Fair Ratio

What is L6J's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

L6J PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	41.5x
Fair PS Ratio	0.02x

Price-To-Sales vs Fair Ratio: L6J is expensive based on its Price-To-Sales Ratio (41.5x) compared to the estimated Fair Price-To-Sales Ratio (0x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.